AnaSpec opens new GMP manufacturing facility

Located adjacent to its current San Jose, California-based headquarters, the expansion provides an additional 5000sqft of dedicated GMP space including two class 10,000 clean rooms.

Optimized for bulk active pharmaceutical ingredient manufacturing, AnaSpec’s GMP peptide services offer greater than 98% purity peptides with QC product release testing, stability studies, and full documentation for drug master files.

Frank Hong, CEO of AnaSpec, said: “The need for GMP-grade peptides is growing. The expansion of our dedicated GMP manufacturing facilities will allow us to more fully address the stringent requirements of our customers.”